A recent study showed that the INF-γ ultrasensitive rapid immunosuspension assay (IRISA-TB) demonstrated a higher specificity and rule-in value than ADA in a high-TB-burden setting where HIV is endemic (Meldau et al., 2019). This evidence concerns the gene ADA and tuberculosis.